✦ LIBER ✦

1167 PRE-TREATMENT IP-10 LEVELS AND IL28B GENOTYPE IN PREDICTION OF SVR IN PRIOR TREATMENT-EXPERIENCED GENOTYPE 1 HCV PATIENTS TREATED WITH TELAPREVIR/PEGINTERFERON/RIBAVIRIN IN THE REALIZE STUDY

✍ Scribed by Vijgen, L.; Talloen, W.; Scholliers, A.; Johansson, S.; Tuefferd, M.; De Meyer, S.; Witek, J.; Fanning, G.; Picchio, G.; Pol, S.; Zeuzem, S.; Aerssens, J.

Book ID: 122625802
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 59 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(12)61179-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

T-26 Impact of anemia and ribavirin dose

T-26 Impact of anemia and ribavirin dose reduction on SVR to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure in the Phase III REALIZE study

✍ P. Andreone; S. Roberts; S. Pol; Z. Younossi; M. Diago; E.J. Lawitz; R. Focaccia 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 79 KB

11 IMPACT OF IL28B GENOTYPE AND PRETREAT

11 IMPACT OF IL28B GENOTYPE AND PRETREATMENT SERUM IP-10 IN TREATMENT-NAIVE GENOTYPE-1 HCV PATIENTS TREATED WITH TMC435 IN COMBINATION WITH PEGINTERFERONa-2A AND RIBAVIRIN IN PILLAR STUDY

✍ J. Aerssens; G. Fanning; A. Scholliers; O. Lenz; M. Peeters; G. De Srnedt; M. Fr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 63 KB

T-27 Efficacy and safety of telaprevir-b

T-27 Efficacy and safety of telaprevir-based regimens in cirrhotic patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: subanalysis of the REALIZE Phase III study

✍ P. Andreone; S. Pol; S. Roberts; Z. Younossi; M. Diago; E.J. Lawitz; R. Focaccia 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

T-29 Predictors of virologic response wi

T-29 Predictors of virologic response with telaprevir-based combination treatment in HCV genotype 1-infected patients with prior peginterferon/ribavirin treatment failure: post-hoc analysis of the phase III REALIZE study

✍ P. Andreone; T. Berg; S. Pol; S. Roberts; Z. Younossi; M. Diago; E.J. Lawitz; R. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Combination of Vaniprevir With Peginterf

Combination of Vaniprevir With Peginterferon and Ribavirin Significantly Increases the Rate of SVR in Treatment-Experienced Patients With Chronic HCV Genotype 1 Infection and Cirrhosis

✍ Rodriguez–Torres, Maribel; Stoehr, Albrecht; Gane, Edward J.; Serfaty, Lawrence; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 656 KB

T-28 Impact of insulin resistance on vir

T-28 Impact of insulin resistance on virologic response to a telaprevir-based regimen in patients with HCV genotype 1 and prior peginterferon/ribavirin treatment failure: post-hoc analysis of the REALIZE Phase III study

✍ P. Andreone; Z. Younossi; F. Negro; L. Serfaty; S. Pol; M. Diago; S. Zeuzem; E.J 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 81 KB